QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
TSE:BLU

BELLUS Health (BLU) Stock Forecast, Price & News

C$19.63
-0.21 (-1.06%)
(As of 06/1/2023 ET)
Compare
Today's Range
C$19.62
C$19.84
50-Day Range
C$8.68
C$19.84
52-Week Range
C$8.58
C$19.90
Volume
17,033 shs
Average Volume
58,718 shs
Market Capitalization
C$2.49 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
C$20.00

BLU stock logo

About BELLUS Health (TSE:BLU) Stock

BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. The company was incorporated in 1993 and is based in Laval, Canada.

Receive BLU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BELLUS Health and its competitors with MarketBeat's FREE daily newsletter.

BLU Stock News Headlines

Closing Bell: Bellus Health Inc down on Thursday (BLU)
Closing Bell: Bellus Health Inc down on Monday (BLU)
Lithium Has Boomed And This American Stock Is Ready..
Lithium Has Been On A Crazy Rally Over The Last 3 Year's And This Stock Could Be Next!
Closing Bell: Bellus Health Inc up on Friday (BLU)
Instantly Find Hidden Trade Opportunities
There’s a tool that scans and picks the best stocks…how you approach the trades is up to you. But when you’re forecasting 1 – 3 days in advance, it’s not really a guessing game. Stop guessing and start predicting to add consistency to your trades… no matter what happens in the market.
GSK pays £1.6bn for Canada's Bellus Health
Closing Bell: Bellus Health Inc down on Wednesday (BLU)
TSX Recovers After Mid-session Setback, Ends Just Marginally Down
TSX Rises 0.8%, Ends At 1-month High
Canadian Shares Extending Losses As Growth Worries Weight On Sentiment
See More Headlines

BLU Price History

BLU Company Calendar

Last Earnings
3/21/2023
Today
6/01/2023
Next Earnings (Estimated)
8/09/2023

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
40
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$20.00
High Stock Price Forecast
C$24.00
Low Stock Price Forecast
C$16.00
Forecasted Upside/Downside
+1.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
C$-86,790,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$16,000.00
Price / Sales
155,567.75
Cash Flow
C$4.20 per share
Book Value
C$2.91 per share

Miscellaneous

Free Float
N/A
Market Cap
C$2.49 billion
Optionable
Not Optionable
Beta
-0.33

Key Executives

  • Mr. Roberto Francesco Bellini (Age 43)
    Pres, CEO & Director
    Comp: $353.03k
  • Mr. Ramzi Benamar (Age 50)
    Chief Financial Officer
    Comp: $607.33k
  • Dr. Denis Garceau (Age 66)
    Chief Scientific Officer
    Comp: $431.87k
  • Mr. Tony Matzouranis (Age 50)
    Sr. VP of Bus. Devel.
    Comp: $272.89k
  • Dr. Catherine M. Bonuccelli M.D. (Age 65)
    Chief Medical Officer
    Comp: $703.77k
  • Dr. Andreas Orfanos FFPM (Age 64)
    M.B.B.Ch, MBA, Chief Operating Officer
  • Mr. Daniel Matthews
    Director of Investor Relations & Communications
  • Mr. Sebastien Roy (Age 47)
    Corp. Sec.













BLU Stock - Frequently Asked Questions

Should I buy or sell BELLUS Health stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for BELLUS Health in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" BLU shares.
View BLU analyst ratings
or view top-rated stocks.

What is BELLUS Health's stock price forecast for 2023?

3 brokers have issued twelve-month price objectives for BELLUS Health's stock. Their BLU share price forecasts range from C$16.00 to C$24.00. On average, they expect the company's share price to reach C$20.00 in the next year. This suggests a possible upside of 1.9% from the stock's current price.
View analysts price targets for BLU
or view top-rated stocks among Wall Street analysts.

How have BLU shares performed in 2023?

BELLUS Health's stock was trading at C$11.08 on January 1st, 2023. Since then, BLU shares have increased by 77.2% and is now trading at C$19.63.
View the best growth stocks for 2023 here
.

When is BELLUS Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023.
View our BLU earnings forecast
.

How were BELLUS Health's earnings last quarter?

BELLUS Health Inc. (TSE:BLU) posted its earnings results on Tuesday, March, 21st. The company reported ($0.19) earnings per share (EPS) for the quarter. The firm earned $0.01 million during the quarter, compared to analyst estimates of $0.01 million.

What other stocks do shareholders of BELLUS Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BELLUS Health investors own include Exxon Mobil (XOM), Bombardier (BDRBF), AbbVie (ABBV), Energy Transfer (ET), General Electric (GE), Coca-Cola (KO), Alexion Pharmaceuticals (ALXN), Advanced Micro Devices (AMD), Boeing (BA) and Walt Disney (DIS).

What is BELLUS Health's stock symbol?

BELLUS Health trades on the Toronto Stock Exchange (TSX) under the ticker symbol "BLU."

How do I buy shares of BELLUS Health?

Shares of BLU stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is BELLUS Health's stock price today?

One share of BLU stock can currently be purchased for approximately C$19.63.

How much money does BELLUS Health make?

BELLUS Health (TSE:BLU) has a market capitalization of C$2.49 billion and generates C$16,000.00 in revenue each year. The company earns C$-86,790,000.00 in net income (profit) each year or C($0.99) on an earnings per share basis.

How can I contact BELLUS Health?

BELLUS Health's mailing address is 9-275 Armand-Frappier Blvd, LAVAL, QC H7V 4A7, Canada. The official website for the company is www.bellushealth.com. The company can be reached via phone at +1-450-6804500.

This page (TSE:BLU) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -